Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand
James Randall Patrinely*, Arissa C. Young, Henry Quach, Grant R. Williams, Fei Ye, Run Fan, Leora Horn, Kathryn E. Beckermann, Erin A. Gillaspie, Jeffrey A. Sosman, Debra L. Friedman, Javid J. Moslehi, Douglas B. Johnson
Dive into the research topics of 'Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand'. Together they form a unique fingerprint.